Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by D. Huglo
A New Pharmacokinetic Model for 90y-Ibritumomab Tiuxetan Based on 3-Dimensional Dosimetry
Scientific Reports
Multidisciplinary
Related publications
MIRD Dose Estimate Report No. 20: Radiation Absorbed-Dose Estimates for 111In- And 90y-Ibritumomab Tiuxetan
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
Positron Emission Tomography/Computed Tomography Before Treatment as a Predictor of 90y-Ibritumomab Tiuxetan Response
Kitakanto Medical Journal
Medicine
Full-Dose 90Y Ibritumomab Tiuxetan Therapy Is Safe in Patients With Prior Myeloablative Chemotherapy
Clinical Cancer Research
Cancer Research
Oncology
P53-Based Strategy for Protection of Bone Marrow From Y-90 Ibritumomab Tiuxetan
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Radioimmunotherapy for B-Cell Lymphoma: Y90 Ibritumomab Tiuxetan and I131 Tositumomab
Oncogene
Cancer Research
Genetics
Molecular Biology
Radioimmunotherapy With 90y-Ibritumomab Tiuxetan Is a Safe and Efficient Treatment for Patients With B-Cell Lymphoma Relapsed After Auto-Sct: An Analysis of the International RIT-Network
Bone Marrow Transplantation
Transplantation
Hematology
SPECT/CT 90y-Bremsstrahlung Images for Dosimetry During Therapy
ecancermedicalscience
Cancer Research
Oncology
A Physiologically-Based Pharmacokinetic Model for Vancomycin
SIAM Undergraduate Research Online
Partition Model-Based 99mTc-Maa SPECT/CT Predictive Dosimetry Compared With 90Y TOF PET/CT Posttreatment Dosimetry in Radioembolization of Hepatocellular Carcinoma: A Quantitative Agreement Comparison
Journal of Nuclear Medicine
Medicine
Nuclear Medicine
Radiology
Imaging
